{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:47:36Z","timestamp":1792788456191,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea","award":["2023R1A2C1003916"],"award-info":[{"award-number":["2023R1A2C1003916"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Research Foundation of Korea","award":["RS-2025-02214129"],"award-info":[{"award-number":["RS-2025-02214129"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2026-25480385"],"award-info":[{"award-number":["RS-2026-25480385"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Promoter DNA hypermethylation is a key epigenetic mechanism of gene silencing in cancer, yet the DNA hypermethylome of oral squamous cell carcinoma (OSCC) and its prognostic relevance remain poorly characterized. Here, we systematically identified and validated novel hypermethylated genes with prognostic significance in OSCC using a genome-wide discovery and multi-platform validation strategy. Candidate genes were first identified by pharmacologic demethylation combined with RNA sequencing across OSCC cell lines, then validated by quantitative RT-PCR, methylation-specific PCR, and bisulfite sequencing in OSCC cell lines, normal oral mucosa, and primary OSCC tumors, with independent confirmation in the TCGA-HNSC dataset. Immunohistochemistry confirmed protein-level silencing, and Kaplan-Meier survival analysis assessed prognostic significance across both cohorts. This pipeline identified five candidate genes,\n                    <jats:italic>GPX3, ANG, CTGF, GPRC5B<\/jats:italic>\n                    , and\n                    <jats:italic>BAMBI<\/jats:italic>\n                    , exhibiting cancer-specific promoter hypermethylation associated with transcriptional and protein silencing in OSCC. Validation in oral cavity tumor samples extracted from the TCGA-HNSC dataset confirmed tumor-specific hypermethylation and revealed significant inverse correlations between methylation and expression for\n                    <jats:italic>GPX3, GPRC5B<\/jats:italic>\n                    , and\n                    <jats:italic>CTGF<\/jats:italic>\n                    . Notably, CTGF hypermethylation was independently associated with poor overall survival in both cohorts (institutional cohort, p=0.03; oral tumor subset from TCGA-HNSC, p=0.01), and a combined\n                    <jats:italic>ANG+CTGF<\/jats:italic>\n                    methylation signature showed superior and reproducible prognostic performance across both platforms. Pathway analysis linked these genes to epithelial-mesenchymal transition and interferon response signaling. This study establishes the first validated DNA methylation biomarker panel for OSCC prognosis, identifying\n                    <jats:italic>CTGF<\/jats:italic>\n                    hypermethylation as a robust prognostic driver with translational potential for clinical risk stratification.\n                  <\/jats:p>","DOI":"10.1186\/s43556-026-00584-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:01:45Z","timestamp":1789599705000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome-based epigenetic screening identifies DNA hypermethylation signatures as prognostic biomarkers in oral squamous cell carcinoma"],"prefix":"10.1186","volume":"7","author":[{"given":"Yu Kyeong","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Su","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keunsoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Ryoun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8341-330X","authenticated-orcid":false,"given":"Joo Mi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"584_CR1","doi-asserted-by":"publisher","first-page":"101086","DOI":"10.1016\/j.ctarc.2025.101086","volume":"46","author":"A Singh","year":"2026","unstructured":"Singh A. Contemporary insights into head and neck cancers: Epidemiology, molecular biology, diagnosis, and therapeutic advances. Cancer Treat Res Comm. 2026;46:101086. https:\/\/doi.org\/10.1016\/j.ctarc.2025.101086.","journal-title":"Cancer Treat Res Comm"},{"issue":"18","key":"584_CR2","doi-asserted-by":"publisher","first-page":"3156","DOI":"10.3390\/cancers16183156","volume":"16","author":"J Kijowska","year":"2024","unstructured":"Kijowska J, Grzegorczyk J, Gliwa K, J\u0119dras A, Sitarz M. Epidemiology, diagnostics, and therapy of oral cancer\u2014update review. Cancers (Basel). 2024;16(18):3156. https:\/\/doi.org\/10.3390\/cancers16183156.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"584_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12903-024-04690-z","volume":"24","author":"L Dong","year":"2024","unstructured":"Dong L, Xue L, Cheng W, Tang J, Ran J, Li Y. Comprehensive survival analysis of oral squamous cell carcinoma patients undergoing initial radical surgery. BMC Oral Health. 2024;24(1):919. https:\/\/doi.org\/10.1186\/s12903-024-04690-z.","journal-title":"BMC Oral Health"},{"issue":"21","key":"584_CR4","doi-asserted-by":"publisher","first-page":"1900667","DOI":"10.1002\/advs.201900667","volume":"6","author":"Q Tang","year":"2019","unstructured":"Tang Q, Xie M, Yu S, Zhou X, Xie Y, Chen G, et al. Periodic oxaliplatin administration in synergy with PER2-mediated PCNA transcription repression promotes chronochemotherapeutic efficacy of OSCC. Adv Sci. 2019;6(21):1900667. https:\/\/doi.org\/10.1002\/advs.201900667.","journal-title":"Adv Sci"},{"issue":"6","key":"584_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"584_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s10555-016-9625-1","volume":"35","author":"S Ausoni","year":"2016","unstructured":"Ausoni S, Boscolo-Rizzo P, Singh B, Da Mosto MC, Spinato G, Tirelli G, et al. Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives. Cancer Metastasis Rev. 2016;35(3):413\u201326. https:\/\/doi.org\/10.1007\/s10555-016-9625-1.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"584_CR7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.6004\/jnccn.2012.0084","volume":"10","author":"S Baxi","year":"2012","unstructured":"Baxi S, Fury M, Ganly I, Rao S, Pfister DG. Ten years of progress in head and neck cancers. J Natl Compr Canc Netw. 2012;10(7):806\u201310. https:\/\/doi.org\/10.6004\/jnccn.2012.0084.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"584_CR8","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14(10):1783\u2013809. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0296.","journal-title":"Cancer Discov"},{"key":"584_CR9","doi-asserted-by":"publisher","unstructured":"Baylin SB, Jones PA. Epigenetic determinants of cancer. Cold Spring Harb Perspect Biol. 2016;8(9). https:\/\/doi.org\/10.1101\/cshperspect.a019505.","DOI":"10.1101\/cshperspect.a019505"},{"issue":"7","key":"584_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12032-017-0983-5","volume":"34","author":"A Burassakarn","year":"2017","unstructured":"Burassakarn A, Pientong C, Sunthamala N, Chuerduangphui J, Vatanasapt P, Patarapadungkit N, et al. Aberrant gene promoter methylation of E-cadherin, p16INK4a, p14ARF, and MGMT in Epstein-Barr virus-associated oral squamous cell carcinomas. Med Oncol. 2017;34(7):128. https:\/\/doi.org\/10.1007\/s12032-017-0983-5.","journal-title":"Med Oncol"},{"issue":"1","key":"584_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ijc.11028","volume":"105","author":"M Viswanathan","year":"2003","unstructured":"Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma. Int J Cancer. 2003;105(1):41\u20136. https:\/\/doi.org\/10.1002\/ijc.11028.","journal-title":"Int J Cancer"},{"issue":"1","key":"584_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13148-019-0715-0","volume":"11","author":"SY Kim","year":"2019","unstructured":"Kim SY, Han YK, Song JM, Lee CH, Kang K, Yi JM, et al. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC). Clin Epigen. 2019;11(1):116. https:\/\/doi.org\/10.1186\/s13148-019-0715-0.","journal-title":"Clin Epigen"},{"issue":"9","key":"584_CR13","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1371\/journal.pgen.0030157","volume":"3","author":"KE Schuebel","year":"2007","unstructured":"Schuebel KE, Chen W, Cope L, Gl\u00f6ckner SC, Suzuki H, Yi JM, et al. Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet. 2007;3(9):1709\u201323. https:\/\/doi.org\/10.1371\/journal.pgen.0030157.","journal-title":"PLoS Genet"},{"issue":"23","key":"584_CR14","doi-asserted-by":"publisher","first-page":"6544","DOI":"10.1158\/1078-0432.CCR-12-3224","volume":"19","author":"JM Yi","year":"2013","unstructured":"Yi JM, Guzzetta AA, Bailey VJ, Downing SR, Van Neste L, Chiappinelli KB, et al. Novel methylation biomarker panel for the early detection of pancreatic cancer. Clinical Can Res. 2013;19(23):6544\u201355. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3224.","journal-title":"Clinical Can Res"},{"issue":"7798","key":"584_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41586-020-2054-x","volume":"579","author":"Z Lu","year":"2020","unstructured":"Lu Z, Zou J, Li S, Topper MJ, Tao Y, Zhang H, et al. Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020;579(7798):284\u201390. https:\/\/doi.org\/10.1038\/s41586-020-2054-x.","journal-title":"Nature"},{"issue":"12","key":"584_CR16","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1158\/1078-0432.CCR-12-3751","volume":"19","author":"J Jeschke","year":"2013","unstructured":"Jeschke J, O\u2019Hagan HM, Zhang W, Vatapalli R, Calmon MF, Danilova L, et al. Frequent inactivation of cysteine dioxygenase type 1 contributes to survival of breast cancer cells and resistance to anthracyclines. Clin Can Res. 2013;19(12):3201\u201311. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3751.","journal-title":"Clin Can Res"},{"key":"584_CR17","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/416552a","volume":"416","author":"I Rhee","year":"2002","unstructured":"Rhee I, et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature. 2002;416:552\u20136. https:\/\/doi.org\/10.1038\/416552a.","journal-title":"Nature"},{"issue":"2","key":"584_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/ng892","volume":"31","author":"H Suzuki","year":"2002","unstructured":"Suzuki H, Gabrielson E, Chen W, Anbazhagan R, van Engeland M, Weijenberg MP, et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet. 2002;31(2):141\u20139. https:\/\/doi.org\/10.1038\/ng892.","journal-title":"Nat Genet"},{"issue":"10","key":"584_CR19","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa J-PJ, Baylin S. Targeting the cancer epigenome for therapy. Nature Rev Genet. 2016;17(10):630\u201341. https:\/\/doi.org\/10.1038\/nrg.2016.93.","journal-title":"Nature Rev Genet"},{"issue":"23","key":"584_CR20","doi-asserted-by":"publisher","first-page":"14624","DOI":"10.3390\/ijms232314624","volume":"23","author":"YK Han","year":"2022","unstructured":"Han YK, Park HY, Park SG, Hwang JJ, Park HR, Yi JM. Promoter methylation of cancer stem cell surface markers as an epigenetic biomarker for prognosis of oral squamous cell carcinoma. Int J Mol Sci. 2022;23(23):14624. https:\/\/doi.org\/10.3390\/ijms232314624.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"584_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med. 2003;349(21):2042\u201354. https:\/\/doi.org\/10.1056\/NEJMra023075.","journal-title":"N Engl J Med"},{"issue":"11","key":"584_CR22","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","volume":"37","author":"A Nishiyama","year":"2021","unstructured":"Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012\u201327. https:\/\/doi.org\/10.1016\/j.tig.2021.05.002.","journal-title":"Trends Genet"},{"key":"584_CR23","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1056\/NEJMra072067","volume":"358","author":"M Esteller","year":"2008","unstructured":"Esteller M. Epigenetics in cancer. N Engl J Med. 2008;358:1148\u201359. https:\/\/doi.org\/10.1056\/NEJMra072067.","journal-title":"N Engl J Med"},{"key":"584_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1146\/annurev-pathol-042220-022304","volume":"17","author":"A Papanicolau-Sengos","year":"2022","unstructured":"Papanicolau-Sengos A, Aldape K. DNA methylation profiling: an emerging paradigm for cancer diagnosis. Annu Rev Pathol. 2022;17:295\u2013321. https:\/\/doi.org\/10.1146\/annurev-pathol-042220-022304.","journal-title":"Annu Rev Pathol"},{"key":"584_CR25","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.3390\/cancers13133373","volume":"13","author":"M Matuszczak","year":"2021","unstructured":"Matuszczak M, Schalken JA, Salagierski M. Prostate cancer liquid biopsy biomarkers\u2019 clinical utility in diagnosis and prognosis. Cancers. 2021;13:3373. https:\/\/doi.org\/10.3390\/cancers13133373.","journal-title":"Cancers"},{"issue":"2","key":"584_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1210\/edrv.20.2.0360","volume":"20","author":"DR Brigstock","year":"1999","unstructured":"Brigstock DR. The connective tissue growth factor\/cysteine- rich 61\/nephroblastoma overexpressed (CCN) family. Endocr Rev. 1999;20(2):189\u2013206. https:\/\/doi.org\/10.1210\/edrv.20.2.0360.","journal-title":"Endocr Rev"},{"issue":"1","key":"584_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1006\/excr.1999.4456","volume":"248","author":"LF Lau","year":"1999","unstructured":"Lau LF, Lam SCT. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res. 1999;248(1):44\u201357. https:\/\/doi.org\/10.1006\/excr.1999.4456.","journal-title":"Exp Cell Res"},{"issue":"6","key":"584_CR28","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cord\u00f3n-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3(6):537\u201349. https:\/\/doi.org\/10.1016\/s1535-6108(03)00132-6.","journal-title":"Cancer Cell"},{"issue":"7","key":"584_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1179\/016164102101200573","volume":"24","author":"LH Pan","year":"2002","unstructured":"Pan LH, Beppu T, Kurose A, Yamauchi K, Sugawara A, Suzuki M, et al. Neoplastic cells and proliferating endothelial cells express connective tissue growth factor (CTGF) in glioblastoma. Neurol Res. 2002;24(7):677\u201383. https:\/\/doi.org\/10.1179\/016164102101200573.","journal-title":"Neurol Res"},{"issue":"4","key":"584_CR30","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00268-001-0242-x","volume":"26","author":"A Koliopanos","year":"2002","unstructured":"Koliopanos A, Friess H, di Mola FF, Tang W-H, Kubulus D, Brigstock D, et al. Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg. 2002;26(4):420\u20137. https:\/\/doi.org\/10.1007\/s00268-001-0242-x.","journal-title":"World J Surg."},{"issue":"4","key":"584_CR31","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/sj.onc.1202395","volume":"18","author":"C Wenger","year":"1999","unstructured":"Wenger C, Ellenrieder V, Alber B, Lacher U, Menke A, Hameister H, et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene. 1999;18(4):1073\u201380. https:\/\/doi.org\/10.1038\/sj.onc.1202395.","journal-title":"Oncogene"},{"issue":"1","key":"584_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.gastro.2004.10.007","volume":"128","author":"BR Lin","year":"2005","unstructured":"Lin BR, Chang CC, Che TF, Chen ST, Chen RJC, Yang CY, et al. Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology. 2005;128(1):9\u201323. https:\/\/doi.org\/10.1053\/j.gastro.2004.10.007.","journal-title":"Gastroenterology"},{"issue":"8","key":"584_CR33","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1158\/1541-7786.MCR-06-0029","volume":"4","author":"W Chien","year":"2006","unstructured":"Chien W, Yin D, Gui D, Mori A, Frank JM, Said J, et al. Suppression of cell proliferation and signaling transduction by connective tissue growth factor in non\u2013small cell lung cancer cells. Mol Cancer Res. 2006;4(8):591\u20138. https:\/\/doi.org\/10.1158\/1541-7786.MCR-06-0029.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"584_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1475-2867-3-15","volume":"3","author":"N Planque","year":"2003","unstructured":"Planque N, Perbal B. A structural approach to the role of CCN (CYR61\/CTGF\/NOV) proteins in tumourigenesis. Cancer Cell Int. 2003;3(1):15. https:\/\/doi.org\/10.1186\/1475-2867-3-15.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"584_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1084\/jem.187.3.289","volume":"187","author":"Y Hashimoto","year":"1998","unstructured":"Hashimoto Y, Shindo-Okada N, Tani M, Nagamachi Y, Takeuchi K, Shiroishi T, et al. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61\/Cef10, and neuroblastoma overexpressed gene) family, suppresses in vivo tumor growth and metastasis of K-1735 murine melanoma cells. J Exp Med. 1998;187(3):289\u201396. https:\/\/doi.org\/10.1084\/jem.187.3.289.","journal-title":"J Exp Med"},{"issue":"50","key":"584_CR36","doi-asserted-by":"publisher","first-page":"47709","DOI":"10.1074\/jbc.M107878200","volume":"276","author":"X Tong","year":"2001","unstructured":"Tong X, Xie D, O\u2019Kelly J, Miller CW, Muller-Tidow C, Koeffler HP. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer*. J Biol Chem. 2001;276(50):47709\u201314. https:\/\/doi.org\/10.1074\/jbc.M107878200.","journal-title":"J Biol Chem"},{"issue":"13","key":"584_CR37","doi-asserted-by":"publisher","first-page":"11465","DOI":"10.1074\/jbc.M210945200","volume":"278","author":"LL Soon","year":"2003","unstructured":"Soon LL, Yie TA, Shvarts A, Levine AJ, Su F, Tchou-Wong KM. Overexpression of WISP-1 down-regulated motility and invasion of lung cancer cells through inhibition of Rac activation. J Biol Chem. 2003;278(13):11465\u201370. https:\/\/doi.org\/10.1074\/jbc.M210945200.","journal-title":"J Biol Chem"},{"issue":"5","key":"584_CR38","doi-asserted-by":"publisher","first-page":"djh059","DOI":"10.1093\/jnci\/djh059","volume":"96","author":"CC Chang","year":"2004","unstructured":"Chang CC, Shih JY, Jeng YM, Su JL, Lin BZ, Chen ST, et al. Connective tissue growth factor and its role in lung adenocarcinoma invasion and metastasis. J Nat Cancer Inst. 2004;96(5):djh059. https:\/\/doi.org\/10.1093\/jnci\/djh059.","journal-title":"J Nat Cancer Inst"},{"issue":"2","key":"584_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0304-3835(02)00718-8","volume":"192","author":"NH Moritani","year":"2003","unstructured":"Moritani NH, Kubota S, Nishida T, Kawaki H, Kondo S, Sugahara T, et al. Suppressive effect of overexpressed connective tissue growth factor on tumor cell growth in a human oral squamous cell carcinoma-derived cell line. Cancer Lett. 2003;192(2):205\u201314. https:\/\/doi.org\/10.1016\/s0304-3835(02)00718-8.","journal-title":"Cancer Lett"},{"issue":"4C","key":"584_CR40","first-page":"2343","volume":"28","author":"T Shimo","year":"2008","unstructured":"Shimo T, Kubota S, Goda T, Yoshihama Y, Kurio N, Nishida T, et al. Clinical significance and pathogenic function of connective tissue growth factor (CTGF\/CCN2) in osteolytic mandibular squamous cell carcinoma. Anticancer Res. 2008;28(4C):2343.","journal-title":"Anticancer Res"},{"issue":"19","key":"584_CR41","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1038\/onc.2011.423","volume":"31","author":"MH Yang","year":"2012","unstructured":"Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MYP, et al. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504\/FOXP1 signalling. Oncogene. 2012;31(19):2401\u201311. https:\/\/doi.org\/10.1038\/onc.2011.423.","journal-title":"Oncogene"},{"issue":"1","key":"584_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics."},{"issue":"18","key":"584_CR43","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93(18):9821\u20136. https:\/\/doi.org\/10.1073\/pnas.93.18.9821.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"584_CR44","doi-asserted-by":"publisher","unstructured":"The Cancer Genome Atlas, Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576. https:\/\/doi.org\/10.1038\/nature14129.","DOI":"10.1038\/nature14129"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-026-00584-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-026-00584-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T23:01:46Z","timestamp":1789599706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-026-00584-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1186\/s43556-026-00584-4","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"22 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and approved by the ethics committee of the Institutional Review Boards (IRB) of Pusan National University Dental Hospital (IRB No. PNUDH-2019-046) and written informed consent was obtained from all patients.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"173"}}